ISDA

Deposition Date 2020-02-04

Release Date 2020-04-08

Last Version Date 2024-10-16

Entry Detail

PDB ID:

6LVK

Keywords:

TRANSFERASE

Title:

Crystal structure of FGFR2 in complex with 1,3,5-triazine derivative

Biological Source:

Source Organism:

Homo sapiens (Taxon ID: 9606)

Host Organism:

Escherichia coli

Method Details:

Experimental Method:

X-RAY DIFFRACTION

Resolution:

2.29 Å

R-Value Free:

0.24

R-Value Work:

0.20

R-Value Observed:

0.20

Space Group:

P 2 21 21

Download Validation Report

Macromolecular Entities

Protein Blast

Polymer Type:polypeptide(L)
Molecule:Fibroblast growth factor receptor 2
Gene (Uniprot):FGFR2
Chain IDs:A, B
Chain Length:313
Number of Molecules:2
Biological Source:Homo sapiens

UniProt ID:P21802 Pfam ID:PF07714 EC:2.7.10.1

Modified Residue

Compound ID	Chain ID	Parent Comp ID	Details	2D Image
PTR	A	TYR	modified residue

Ligand Molecules

EVC

SO4

Primary Citation

Structure-based drug design of 1,3,5-triazine and pyrimidine derivatives as novel FGFR3 inhibitors with high selectivity over VEGFR2.

Kuriwaki, I, Kameda, M, Hisamichi, H, Kikuchi, S, Iikubo, K, Kawamoto, Y, Moritomo, H, Kondoh, Y, Amano, Y, Tateishi, Y, Echizen, Y, Iwai, Y, Noda, A, Tomiyama, H, Suzuki, T, Hirano, M.Show

Bioorg.Med.Chem. 28 115453 115453 (2020)

PMID: 32278710 DOI: 10.1016/j.bmc.2020.115453

Abstact

Fibroblast growth factor receptor 3 (FGFR3) is an attractive therapeutic target for the treatment of bladder cancer. We identified 1,3,5-triazine derivative 18b and pyrimidine derivative 40a as novel structures with potent and highly selective FGFR3 inhibitory activity over vascular endothelial growth factor receptor 2 (VEGFR2) using a structure-based drug design (SBDD) approach. X-ray crystal structure analysis suggests that interactions between 18b and amino acid residues located in the solvent region (Lys476 and Met488), and between 40a and Met529 located in the back pocket of FGFR3 may underlie the potent FGFR3 inhibitory activity and high kinase selectivity over VEGFR2.

Legend

Protein

Chemical

Disease

Primary Citation of related structures